ASCEND BY NTHRYS
Research Abroad Products

Exomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 133–144 of 200 project topics
Liquid Biopsy Exosome Isolation and Characterization Tool
An automated bench-top instrument that isolates, concentrates, and characterizes exosomes from minimal blood volume using immunomagnetic and size-exclusion technologies. Positions as the gold-standard platform for clinical adoption, generating recurring service fees through instrument leasing, maintenance contracts, and consumable sales to hospital networks.
Exosome Biomarker Discovery Platform Dev Click to view more details →
Circulating Tumor Exosome Cancer Monitoring Diagnostic Service
A clinical diagnostic service that analyzes tumor-derived exosomal DNA and proteins to monitor cancer progression, treatment response, and recurrence risk in real-time. Captures high-value LDT reimbursement fees ($2,000-$5,000 per test) while licensing algorithms to oncology centers seeking differentiated monitoring capabilities.
Exosome Biomarker Discovery Platform Dev Click to view more details →
Neurodegenerative Disease Exosome Biomarker Reference Database
A subscription-based bioinformatics platform hosting validated exosomal biomarker signatures for Alzheimer''s, Parkinson''s, and ALS with machine learning prediction models. Monetizes through SaaS licensing to pharma companies conducting clinical trials and diagnostic companies developing next-generation neurodegeneration screening tests.
Exosome Biomarker Discovery Platform Dev Click to view more details →
Point-of-Care Exosome Rapid Test Platform Development
A microfluidic cartridge-based system enabling 15-minute exosomal biomarker detection at bedside or in-office settings without laboratory infrastructure. Targets primary care, urgent care, and remote healthcare markets with recurring cartridge sales and software subscriptions while capturing first-mover advantage in POC exosome testing.
Exosome Biomarker Discovery Platform Dev Click to view more details →
Multi-Cancer Exosome Panel Commercial Development and Launch
A validated exosomal biomarker panel detecting 10+ cancer types from single blood draw with companion diagnostic software and clinical interpretation tools. Launches as premium liquid biopsy offering through strategic partnerships with cancer centers and genetics labs, generating $3,000+ per test with 70%+ gross margins.
Exosome Biomarker Discovery Platform Dev Click to view more details →
Exosome Biomarker Data Management and Reporting Software Suite
An enterprise software platform managing exosome sample workflows, biomarker analysis results, and clinical reporting with HIPAA-compliant architecture and LIS integration. Delivers recurring SaaS revenue through per-user licensing, data storage fees, and professional services to diagnostic networks and hospital systems adopting exosome testing.
Exosome Biomarker Discovery Platform Dev Click to view more details →
Cardiovascular Risk Stratification Exosome Biomarker Service
A clinical testing service leveraging cardiac exosomal biomarkers to predict heart disease, myocardial infarction, and heart failure risk with superior accuracy to traditional markers. Captures preventive medicine market reimbursement while licensing biomarker algorithms to cardiology EHR platforms and insurance providers seeking cost-reduction through early intervention.
Exosome Biomarker Discovery Platform Dev Click to view more details →
Therapeutic Exosome Manufacturing Quality Control Analytics Platform
A specialized analytics platform providing real-time exosome characterization (size, concentration, surface markers, payload) for cell therapy and regenerative medicine manufacturers. Generates revenue through software licensing, per-batch analysis fees, and compliance consulting services to enable scaled manufacturing of exosome-based therapeutics meeting regulatory specifications.
Exosome Biomarker Discovery Platform Dev Click to view more details →
Automated High-Throughput Exosome Isolation Instrument Platform
A benchtop instrument that automates exosome isolation from biological fluids using magnetic nanoparticles and microfluidic processing to enable rapid, standardized sample preparation. This platform generates recurring revenue through instrument sales, consumable cartridges, and service agreements while reducing per-sample processing costs by 70%.
Exosome Isolation Technology Platform Dev Click to view more details →
Cloud-Based Exosome Biomarker Data Analytics SaaS Platform
A subscription-based software platform that integrates exosome isolation data, proteomics analysis, and machine learning algorithms to identify disease biomarkers and predict clinical outcomes. The SaaS model delivers predictable monthly recurring revenue while enabling pharmaceutical and diagnostics companies to accelerate biomarker validation studies.
Exosome Isolation Technology Platform Dev Click to view more details →
Microfluidic Chip Technology for Size-Based Exosome Separation
Disposable microfluidic chips incorporating asymmetric flow field-flow fractionation (AF4) technology to isolate and separate exosomes by size and density with high purity and yield. Revenue streams include chip manufacturing, licensing agreements with OEMs, and white-label integration into diagnostic and research platforms.
Exosome Isolation Technology Platform Dev Click to view more details →
Magnetic Bead Conjugate Kit Portfolio for Clinical Diagnostics
A comprehensive product line of pre-conjugated magnetic beads targeting cancer-related, cardiovascular, and neurodegenerative disease biomarkers on exosome surfaces for point-of-care and lab testing. This consumables-based business model ensures high-margin recurring purchases across hospitals, diagnostic labs, and clinical research centers globally.
Exosome Isolation Technology Platform Dev Click to view more details →